| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |